Accéder au contenu
Merck

Association of blood type and patient characteristics with ovarian reserve.

Fertility and sterility (2013-09-24)
Kathryn S Timberlake, Kristie L Foley, Bradley S Hurst, Michelle L Matthews, Rebecca S Usadi, Paul B Marshburn
RÉSUMÉ

To assess whether blood type was associated with diminished ovarian reserve (DOR) (day-3 follicle-stimulating hormone level >10 IU/L), controlling for history of tobacco smoking, body mass index (BMI), history of endometriosis, ovarian surgery, previous pregnancy, and maternal age. Cross-sectional study. Academic medical center, Division of Reproductive Endocrinology and Infertility. Women undergoing in vitro fertilization (IVF) from 2006-2011 (n = 305). None. Presence of DOR in relation to a patient's blood type. Other investigators have reported an increased risk for DOR in patients with blood type O and a protective effect on ovarian reserve for blood type A. We observed no association between a woman's blood type and DOR. We found an increased risk for DOR in patients aged 35 and older. Obesity (BMI ≥ 30 vs. BMI <25) was associated with lower odds of DOR. In comparison with blood type A, blood type O is not associated with an increase in DOR. We found no clinical implications for using blood type as a risk factor for DOR.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Follicle Stimulating Hormone from human pituitary, ~7,000 IU/mg (powder)